Sweden's Sleep Cycle AB Q2 net sales fall 21.5% on challenging market

Sleep Cycle AB (publ)

26/08/2026 06:44

Overview
Sweden sleep app provider's Q2 net sales fell 21.5% yr/yr amid challenging market
B2B segment grew 26.9% and accounted for 15.1% of Q2 net sales
Company signed new licensing agreements with Ultrahuman and Ant Group in Q3

Outlook
Company expects Q3 B2B revenue to exceed SEK 9 mln, up over 30% year-on-year
Sleep Cycle sees full-year net sales declining, but at a slower rate in H2 than H1's -20.2%
Company maintains full-year reported operating margin guidance of about 5%, or 9% excluding one-offs

Result Drivers
CHALLENGING MARKET - Co said net sales decline was due to continued challenging market for sleep apps
B2B GROWTH - B2B segment revenue grew 26.9% and accounted for 15.1% of net sales, per CEO Erik Jivmark
ONE-OFF COSTS - Q2 results affected by SEK 10.9 mln in costs affecting comparability

Company press release: ID:nMFN7JBbXW

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
 
SEK 49.90 mln
 
Q2 Adjusted EBIT
 
SEK 3.38 mln
 
Q2 Adjusted EBIT Margin
 
6.80%
 
Q2 EBIT
 
-SEK 7.54 mln
 
Q2 EBIT Margin
 
-15.10%
 

Analyst Coverage
Wall Street's median 12-month price target for Sleep Cycle AB (publ) is SEK30.50, about 22.2% above its August 25 closing price of SEK24.95
The stock recently traded at 30 times the next 12-month earnings vs. a P/E of 24 three months ago

Reuters Recommended Reads
Aug 25 - Sweden's Ortivus Q2 net sales fall, gross margin declines
Aug 25 - Sweden's SyntheticMR Q2 sales rise, loss narrows on cNeuro strength, India growth
Aug 26 - Smart Eye Q2 net sales rise 53% on royalty revenue

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)